A new version of this title is available
This publication is provided for historical reference only and the information may be out of date.
CADTH Optimal Use Reports
CADTH Optimal Use reports, now renamed to Health Technology Review, are intended to encourage ideal prescribing, purchasing, and use of drugs or other health technologies by health care providers, policy-makers, and consumers. Generally, these are drugs or health technologies that have been available in the marketplace for some time. An Optimal Use project results in a series of documents — typically clinical and economic review reports as well as a recommendations report. CADTH Optimal Use projects are carried out in collaboration with a committee or panel comprising subject‐matter experts, public representatives, and other stakeholders from across Canada.
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent, not-for-profit producer and broker of health technology assessments. Health care decision-makers rely on our work to make evidence-informed policy and practice decisions about drugs and other health technologies.
CADTH Optimal Use Reports was renamed to Health Technology Review on on Oct. 29, 2021, with volume 9.3c.
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/